In pilot study, a peptide controls blood sugar in people with congenital hyperinsulinism (EurekAlert, 1 August 2012)

02 Aug 2012


A US study published in Diabetes investigates the GLP-1 antagonist exendin-(9-39) as a potential treatment for congenital hyperinsulinism.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story